Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 28, 2012; 18(24): 3156-3166
Published online Jun 28, 2012. doi: 10.3748/wjg.v18.i24.3156
Table 1 Characteristics of 7 included randomized controlled trials
Included studiesCountryStudy periodSample sizeComparisonMeasured outcomes
Bansal et al[5], 2010India2007-200830Preoperative ERCP/EST + LC (n = 15) vs LC + LCBDE (n = 15)Successful removal of gallbladder and CBD clearance, complications
Rogers et al[24], 2010United States1997-2003122Preoperative ERCP/EST + LC (n = 61) vs LC + LCBDE (n = 61)Stone clearance from CBD, length of hospital stay, cost of index hospitalization, hospital charges, professional fees, patient acceptance, morbidity, mortality, quality of life scores
Rhodes et al[25], 1998United Kingdom1995-199780Postoperative ERCP/EST + LC (n = 40) vs LC + LCBDE (n = 40)Duct-clearance rates, morbidity, operating time and hospital stay
Cuschieri et al[26], 1999Scotland1994-1997300Preoperative ERCP/EST + LC (n = 150) vs LC + LCBDE (n = 150)Hospital stay, success rates, conversion rates, morbidity and mortality
Nathanson et al[27], 2005Australia1998-200386Postoperative ERCP/EST + LC (n = 45) vs LC + LCBDE (n = 41)Operative time, morbidity, retained stone rate, reoperation rate and hospital stay
Sgourakis et al[28], 2002Greece1997-200078Preoperative ERCP/EST + LC (n = 42) vs LC + LCBDE (n = 36)Stone clearance, morbidity, mortality, conversion, hospital stay, complications
Noble et al[29], 2009United Kingdom2000-200691Preoperative ERCP/EST + LC (n = 47) vs LC + LCBDE (n = 44)Duct clearance, complications, number of procedures per patient, conversion and hospital stay